Medical Research
Staar Ovarian Cancer
CHICAGO, IL
Total revenue
$300K
Total expenses
$56K
Net assets
$393K
Grants received
$76K
6 grants
EIN
844672869
Tax year
2024
Mission
Staar exists to advocate for and raise funds for research specifically on the low-grade serous carcinoma sub-typle of ovarian cancer in the united states. We drive awareness of the symptobs of ovarian cancer and the under-funding of research for the lgsc sub-type. We strengthen our connections with researchers to understand research needs, funding needs, and historically raised enough funds through donations to give three research grants for lgsoc. One of the funded studies was funded with money donated in 2021.
Programs
3 programs
Awarded research grants for lgsoc
Created and conducted a survery of lgsoc patients perpectives on treatments and doctor interactions which are presented at lgsoc research conference. Plan, support, and hold an externally-led patient focused drug development meeting as directed by the us fda for patients to present their perspectives on living with their rare disease and their daily life with the current treatments. Provide a platform for patients to share their thoughts on drug development and side effects.
Any other marketing research support services that benefits awareness of lgsc sub-type.
Financials
FY 2024
Revenue
Expenses
People
11 listed
CONNIE BELL
DIRECTOR
—
8 hrs/wk
MARK BLAKE
DIRECTOR
—
2 hrs/wk
ELLIE HABIB
DIRECTOR
—
1 hrs/wk
TIFFANY LOCKE
DIRECTOR
—
1 hrs/wk
BAILEY WOLFE
DIRECTOR
—
1 hrs/wk
NICOLE ANDREWS
CHAIR
—
9 hrs/wk
CHRISTINA CAMPBELL
TREASURER
—
3 hrs/wk
MORGAN GAYNOR
SECRETARY
—
3 hrs/wk
KARI NEUMEYER
V-CHAIR MARK
—
10 hrs/wk
EMMA SCHLAMM
DIRECTOR
—
2 hrs/wk
ALYSSA TOOMES
V-CHAIR FUND
—
3 hrs/wk
Grants received
Showing 6 of 6
Funded by
$76K from 5 funders · 6 grants · 2022–2024
$44K · 2 grants · 2023–2024
$15K · 1 grant · 2024
$10K · 1 grant · 2022
$6K · 1 grant · 2022
$50 · 1 grant · 2022